Atlas Trials

Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients

Clinical trial NCT01802970 · COMPLETED

Trial details

NCT number
NCT01802970
Sponsor
Baylor Research Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2012-12-01
Primary completion
2017-01-04
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.